Jubilant Ingrevia commissions new facility for Diketene derivatives at Uttar Pradesh

01 Apr 2024 Evaluate

Jubilant Ingrevia has commissioned a new facility at its manufacturing site for Diketene derivatives at Gajraula, Uttar Pradesh. As a global, integrated life science products and innovative solutions provider, the company presently has over 134 products & innovative solutions commercialised. With over four decades of experience, it has developed proficiency across around 35 key chemistry and technology platforms across its businesses: Specialty, Nutrition and Chemical Intermediates.

The newly commissioned facility adds additional capacity of 2,000 TPA to produce high-value esters. This strengthening of the Diketene and derivatives platform marks a natural evolution of strategy in the Specialty Chemicals segment. This business is pivoting towards accelerated growth and higher margins with the introduction of several downstream derivatives.

In line with its long-term strategic objectives, Jubilant Ingrevia remains committed to commissioning of future phases of Diketene derivatives. In addition to existing clients the expanded range of diketene derivatives will be aimed at a new category of customers in key international markets, including the U.S and E.U regions. 

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.


Jubilant Ingrevia Share Price

801.25 -37.90 (-4.52%)
08-Jan-2025 12:12 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1003.15
SRF 2337.25
Pidilite Inds. 2890.10
Aarti Inds 395.50
Atul 6836.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.